Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herr

Showing results (241-250 of 278) with videos related to

Pageof 28
Sort By:
International Journal of Medical Sciences|January 26, 2026
Deletion of the Mouse Homolog of Human FHR1 (muFHR1) Alleviates Atherosclerosis in ApoE-/- miceLuce Perie, Sarah M Herr, Tomas Ghebreslassie, et al.
Transplantation and Cellular Therapy|July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced CostShernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
Journal of Pathology Informatics|October 3, 2015
A conceptual model for translating omic data into clinical actionTimothy M Herr, Suzette J Bielinski, Erwin Bottinger, et al.
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Cancer Causes & Control : CCC|May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaJennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.
Transplantation and Cellular Therapy|May 24, 2022
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United StatesCaron A Jacobson, Frederick L Locke, Long Ma, et al.
Nature Communications|February 11, 2022
Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myelomaMaximilian Merz, Almuth Maria Anni Merz, Jie Wang, et al.
Blood Advances|March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapyMegan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Blood|November 1, 2021
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamideEphraim J Fuchs, Shannon R McCurdy, Scott R Solomon, et al.
Critical Care Medicine|December 30, 2025
Six-Year Trends in ICU Admission, Management, and Outcomes of Chimeric Antigen Receptor T-Cell Patients in the ICUPrabalini Rajendram, R Scott Stephens, Anne Rain T Brown, et al.
Pageof 28

Showing results (241-250 of 278) with videos related to

Sort By:
Pageof 28
International Journal of Medical Sciences|January 26, 2026
Deletion of the Mouse Homolog of Human FHR1 (muFHR1) Alleviates Atherosclerosis in ApoE-/- miceLuce Perie, Sarah M Herr, Tomas Ghebreslassie, et al.
Transplantation and Cellular Therapy|July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced CostShernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
Journal of Pathology Informatics|October 3, 2015
A conceptual model for translating omic data into clinical actionTimothy M Herr, Suzette J Bielinski, Erwin Bottinger, et al.
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Cancer Causes & Control : CCC|May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaJennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.
Transplantation and Cellular Therapy|May 24, 2022
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United StatesCaron A Jacobson, Frederick L Locke, Long Ma, et al.
Nature Communications|February 11, 2022
Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myelomaMaximilian Merz, Almuth Maria Anni Merz, Jie Wang, et al.
Blood Advances|March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapyMegan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Blood|November 1, 2021
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamideEphraim J Fuchs, Shannon R McCurdy, Scott R Solomon, et al.
Critical Care Medicine|December 30, 2025
Six-Year Trends in ICU Admission, Management, and Outcomes of Chimeric Antigen Receptor T-Cell Patients in the ICUPrabalini Rajendram, R Scott Stephens, Anne Rain T Brown, et al.
Pageof 28